Nuvo Group
Founded Year
2014Stage
Reverse Merger | IPOTotal Raised
$68MMarket Cap
0.10BAbout Nuvo Group
Nuvo Group develops medical devices. It provides expectant mothers with pregnancy care, a prescription-initiated remote pregnancy monitoring and management system, conducts virtual well-being checks and remote non-stress-tests, and more. The company was founded in 2014 and is based in Tel Aviv, Israel.
Loading...
Nuvo Group's Product Videos
ESPs containing Nuvo Group
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The maternal & fetal health screening market helps to improve patient outcomes by offering remote patient monitoring services & medical devices to diagnose and monitor maternal and fetal health conditions, including maternal preeclampsia, premature birth risk, and fetal oxygenation levels during labor. Some companies supplement their screening products with support services for comprehensive care.…
Nuvo Group named as Leader among 15 other companies, including Babyscripts, Bloomlife, and Sera Prognostics.
Nuvo Group's Products & Differentiators
Remote non-stress tests
Under provider prescription, remote NSTs with INVU allow for the completion of non-stress-tests, a common and frequent test administered in the last trimester of high risk pregnancies to monitor fetal heart rate and uterine activity, ensuring that a pregnancy is progressing healthily or to quickly identify when intervention is needed. INVU can be used to monitor NSTs wherever mom is scheduled for an assessment under the supervision of her provider. Mom can sit for the NST from the comfort of her own home and see a high-level view of the data while her provider gets an immediate reading of the detailed data from a session, identical to the strip of data they are used to seeing from in-clinic NSTs.
Loading...
Research containing Nuvo Group
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Nuvo Group in 3 CB Insights research briefs, most recently on Jul 18, 2024.
Jul 18, 2024 report
State of Digital Health Q2’24 Report
Nov 11, 2022 report
How tech is making women’s healthcare more equitable and accessibleExpert Collections containing Nuvo Group
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Nuvo Group is included in 7 Expert Collections, including Baby and Kids Tech.
Baby and Kids Tech
1,281 items
Companies developing tech-enabled products and services that primarily serve babies, children up to approximately 12 years old, and their parents.
Beauty & Personal Care
858 items
These startups aim to provide health treatments, diagnosis tools, and products that do not require a prescription or connection with a health professional to enhance personal wellbeing. This includes supplements, women's health maintenance, OTC medicines, and more.
Conference Exhibitors
5,302 items
Digital Health 50
300 items
The winners of the second annual CB Insights Digital Health 150.
Digital Health
11,257 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Telehealth
3,114 items
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
Nuvo Group Patents
Nuvo Group has filed 44 patents.
The 3 most popular patent topics include:
- midwifery
- obstetrics
- cardiac arrhythmia
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/30/2023 | 4/30/2024 | Tests during pregnancy, Health informatics, Midwifery, Obstetrics, Cardiac arrhythmia | Grant |
Application Date | 1/30/2023 |
|---|---|
Grant Date | 4/30/2024 |
Title | |
Related Topics | Tests during pregnancy, Health informatics, Midwifery, Obstetrics, Cardiac arrhythmia |
Status | Grant |
Latest Nuvo Group News
Nov 22, 2024
News provided by Share this article Share toX – Nuvo Int'l Group Ltd. Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court Approval – – Deal Includes Acquisition of Substantially All of the Company's Assets, Ensuring Business Continuity for Customers, Partners and Employees – TEL AVIV, Israel, Nov. 22, 2024 /PRNewswire/ -- Nuvo Group Ltd. ("Nuvo"), the maker of Invu, a pregnancy monitoring device recently named as one of Time Magazine's Best Inventions of 2024, has entered into a binding term sheet with Nuvo Int'l Group Ltd. ("Nuvo Int'l"), an acquisition company funded by Kips Bay Select LP., and selected Nuvo Int'l as the winning bidder at Nuvo's auction in its sale process under Section 363 of the U.S. Bankruptcy Code. Nuvo Int'l will acquire substantially all of the Company's assets and assume certain of its liabilities for cash and non-cash consideration. "The agreement with Nuvo Int'l marks a significant step in our financial restructuring, and when consummated will allow us to continue to deliver best-in-class pregnancy support to moms-to-be and their doctors," said Rice Powell, CEO of Nuvo. The U.S. Bankruptcy Court hearing to approve the sale is currently scheduled for December 3, 2024. With Court approval, the transaction is expected to close in the first week of December 2024. Nuvo is advised in this matter by Hughes Hubbard & Reed LLP and Morris Nichols Arsht & Tunnell LLP as legal counsel, Teneo Capital LLC as financial advisor, and Intrepid Investment Bankers LLC as investment banker. About Nuvo Nuvo is leading a transformation in pregnancy care by providing clinicians and expectant mothers with access to medically necessary remote pregnancy monitoring anytime, anywhere. Nuvo's INVU™ platform is an FDA-cleared remote pregnancy monitoring and management system. It enables the delivery of remote non-stress tests (NSTs) and maternal and fetal heart rate monitoring, while pioneering new data-driven personalized pathways that Nuvo believes can improve future health outcomes. INVU is being used by leading health providers and research institutions across the US and Israel. Nuvo plans to continue to expand the footprint of sales in the US and Israel and plans to introduce its INVU platform in Europe in 2024, subject to granting of the CE mark it filed in Europe in March 2023, to provide remote access and insights not previously deemed possible. Nuvo is led by a diverse team of experienced business, medical and technology leaders, united in the mission of breaking down barriers to pregnancy care to give every life a better beginning. For more information and complete indications, contraindications, warnings and precautions, and instructions for use, visit www.nuvocares.com . SOURCE Nuvo Group Ltd
Nuvo Group Frequently Asked Questions (FAQ)
When was Nuvo Group founded?
Nuvo Group was founded in 2014.
Where is Nuvo Group's headquarters?
Nuvo Group's headquarters is located at Yigal Alon 94. Street, Tel Aviv.
What is Nuvo Group's latest funding round?
Nuvo Group's latest funding round is Reverse Merger.
How much did Nuvo Group raise?
Nuvo Group raised a total of $68M.
Who are the investors of Nuvo Group?
Investors of Nuvo Group include LAMF Global Ventures Corp. I, MedTech Innovator and Shareholder Value Management.
Who are Nuvo Group's competitors?
Competitors of Nuvo Group include Baymatob and 7 more.
What products does Nuvo Group offer?
Nuvo Group's products include Remote non-stress tests and 1 more.
Who are Nuvo Group's customers?
Customers of Nuvo Group include Axia, CANLab, UAMS and UHP.
Loading...
Compare Nuvo Group to Competitors
Bloomlife operates as a women's health company that focuses on improving maternal health through technology in the healthcare sector. The company offers remote patient monitoring and connected devices that provide data analytics for maternal and fetal health, as well as digital health assessments to manage pregnancies. Bloomlife primarily serves healthcare providers and pregnant women. Bloomlife was formerly known as Bloom Technologies. It was founded in 2014 and is based in San Francisco, California.
Marani Health operates as an artificial intelligence (AI)-powered maternal healthcare technology company focused on improving patient outcomes and enhancing clinical workflows in the healthcare sector. The company offers a platform that delivers individual insights through connected devices, enabling personalized and proactive care for pregnant individuals. Marani Health primarily serves maternity providers, health plans, employers, and patients with its solutions for prenatal and postpartum care. Marani Health was formerly known as Odonata Health. It was founded in 2018 and is based in Oakdale, Minnesota.
Nanit specializes in smart baby monitoring technology within the consumer electronics sector. The company offers products that enable parents to track their baby's sleep, breathing, and overall wellness through a connected camera and app, providing insights and analytics to support child development. Nanit's solutions cater to the needs of modern parents seeking data-driven tools for infant care and development. It was founded in 2014 and is based in New York, New York.
Pera Labs specializes in AI fertility solutions and reproductive health services within the health tech industry. The company offers a range of services including fertility and genomic testing, dietary supplements for fertility, and reproductive health counselling. Pera Labs primarily serves individuals and couples seeking fertility treatments and reproductive wellness. It was founded in 2018 and is based in Philadelphia, Pennsylvania.
Coroflo focuses on innovative technology in the healthcare sector. The company's main product is a nipple shield with inbuilt flow measurement that transfers data to an app, providing accurate, precise, data on breastfeeding. This product primarily caters to the healthcare industry, specifically new mothers and healthcare professionals. It was founded in 2016 and is based in Dublin11, Ireland.
Raydiant Oximetry focuses on improving maternal-fetal medicine by developing noninvasive sensor technology for childbirth. Its main product, Lumerah™, is a fetal pulse oximeter designed to measure fetal oxygen levels accurately and reduce unnecessary cesarean deliveries. The company primarily serves the healthcare sector, offering tools for obstetric providers to evaluate fetal well-being during labor. It was founded in 2016 and is based in San Ramon, California.
Loading...